Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)
USA - English
Share this article
Aion Therapeutic Inc. (CSE: AION) (
Aion Therapeutic or the
Company ) announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical cannabis and medicinal mushroom preparations for the treatment of interstitial cystitis and other bladder diseases, and methods for producing emulsions and nano-emulsions for increasing bioavailability in these formulations. These new additions increase our intellectual property portfolio to a current total of 9 patent applications with more expected in the very near future.